SEC Form 4 · accession 0001644435-16-000002
INTEGRATED BIOPHARMA INC · INBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Laplaca
Director
Period of report
Nov 18, 2016
Accepted (ET)
Nov 22, 2016 · 4:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016504
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.23 | Nov 18, 2016 | A | 50,000 | A | — | Nov 18, 2026 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The option vests 5/12ths (20,831) on grant date (November 18, 2016) and in 7 monthly installments for the remaining 7/12ths (29,169) beginning on December 1, 2016.